FDA declares end to Wegovy and Ozempic shortage
CBSN
The Food and Drug Administration announced Friday it had officially declared an end to the nationwide shortage of Ozempic and Wegovy, medications used for diabetes and weight loss.
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
The FDA's announcement comes months after drugmaker Novo Nordisk told the agency that all dosages of its semaglutide product had become fully available nationwide. The company said in a statement that it confirms the supply of the medications, which are prescription-only, "now meets or exceeds both current and projected U.S. demand."

A panel of appeals court judges handed the Trump administration a major legal victory on Wednesday in its quest to detain large swaths of immigrants living in the country illegally, saying that people who entered the United States without inspection and admission can be detained without bond. Jonah Kaplan and Camilo Montoya-Galvez contributed to this report.

A jury on Wednesday found that Meta and YouTube are liable for creating products that led to harmful and addictive behavior by young users, a landmark decision that could set a legal precedent for similar allegations brought against social media companies. Edited by Alain Sherter and Aimee Picchi In:











